Tango Therapeutics, Inc. (TNGX) Misses Q1 EPS by 1c

Tango Therapeutics, Inc. (NASDAQ: TNGX) reported Q1 EPS of ($0.32), $0.01 worse than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Tango Therapeutics, Inc. (TNGX) click here.

You May Also Be Interested In

• U.S. and Denmark close in on a Greenland deal - Reuters
• Trump says U.S. and Denmark reached permanent security deal over Greenland
• Axion Minerals plans flow-through private placement of up to $440K